UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) March 15, 1999
------------------
COMMONWEALTH BIOTECHNOLOGIES, INC.
----------------------------------
(Exact Name of Registrant as Specified in Charter)
Virgina 001-13467 56-1641133
------- --------- ----------
(State or other jurisdiction of (Commission File Number) (IRS Employer
Incorporation) Identification No.)
601 Biotech Drive, Richmond, Virginia 23235
---------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (804) 648-3820
---------------------
N/A
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events.
On March 15, 1999, Charles A. Mills, submitted his resignation as a
director of the Company. Mr. Mills served as a director since the Company
completed its initial public offering in 1997. Mr. Mills served as a member of
the Audit, Compensation and Nominating Committees of the Company's Board of
Directors. Mr. Mills has elected to focus his attention of the operation of
Anderson & Strudwick Incorporated, a brokerage firm for which he serves as
Chairman. The Company is actively searching for a replacement.
Item 7. Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
Not applicable.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
COMMONWEALTH BIOTECHNOLOGIES, INC.
By: /s/ Robert B. Harris, Ph.D.
-------------------------------
Robert B. Harris, Ph.D.
President
March 19, 1999
